The Peptide Dispatch › Peptide Database › PEG-MGF
PEG-MGF (PEGMGF)
Muscle Research chemical
Reviewed by The Peptide Dispatch Editorial Team · Last reviewed July 6, 2026
TL;DR — PEG-MGF at a Glance
PEG-MGF (PEGMGF) is a muscle peptide, at the research chemical stage in the published literature. PEGylated version of MGF with dramatically extended half-life, allowing systemic rather than site-specific effects.
PEGylated version of MGF with dramatically extended half-life, allowing systemic rather than site-specific effects.
Key Data
Research Status Research chemical Half-Life Several days Administration Subcutaneous injection Doses Reported in Published Studies 200 mcg 2-3x per week
Mechanism of Action
Same as MGF with PEG attachment for extended circulation time and systemic distribution.
Reported Benefits
Systemic MGF effects Extended half-life Muscle growth Recovery
Frequently Asked Questions
What is PEG-MGF?
PEGylated version of MGF with dramatically extended half-life, allowing systemic rather than site-specific effects.
How does PEG-MGF work?
Same as MGF with PEG attachment for extended circulation time and systemic distribution.
What is the research status of PEG-MGF?
PEG-MGF is at the following stage in the published literature: Research chemical. All information is for research and educational purposes only.
What is the half-life of PEG-MGF?
Reported half-life: Several days.
How is PEG-MGF administered in research?
Reported administration route in the literature: Subcutaneous injection. This is not a recommendation for human use.
Educational content, not medical advice. Effects described are drawn from cited research in study subjects.